Enliven Therapeutics Inc
(ELVN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-1991 | 12-1990 | 12-1989 | 12-1988 | |
| Assets | ||||
| Current Assets | ||||
| Other current assets | 1,230 | 756 | 756 | 0 |
| TOTAL | $1,230 | $756 | $756 | $N/A |
| Non-Current Assets | ||||
| PPE Net | N/A | 16,812 | 16,812 | N/A |
| Other Non-Current Assets | 18,680 | 444 | 444 | 0 |
| TOTAL | $18,680 | $17,256 | $17,256 | $N/A |
| Total Assets | $19,910 | $18,012 | $18,012 | $N/A |
| Liabilities | ||||
| Current Liabilities | ||||
| Accounts payable and accrued liabilities | 1,410 | 1,017 | 1,017 | 0 |
| Accrued Expenses | 4,340 | 3,251 | 3,251 | N/A |
| Other current liabilities | 11,620 | 6,965 | 6,965 | N/A |
| TOTAL | $18,620 | $12,006 | $12,006 | $N/A |
| Non-Current Liabilities | ||||
| Other Non-Current Liabilities | 1,370 | 841 | 841 | 0 |
| TOTAL | $3,240 | $4,714 | $4,714 | $N/A |
| Total Liabilities | $21,860 | $16,720 | $16,720 | $N/A |
| Shareholders' Equity | ||||
| Common Shares | 5 | 21,722 | 21,722 | N/A |
| Other shareholders' equity | -350 | 400 | 400 | 0 |
| TOTAL | $31,725 | $22,122 | $22,122 | $N/A |
| Total Liabilities And Equity | $53,585 | $38,842 | $38,842 | $0 |